RESMED INC
For the period ended Mar 31, 2024. Filed Apr 26, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 26, 2024
RMD$234.11-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income (Unaudited)
| PART I – FINANCIAL INFORMATION | Item 1 |
|---|
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
| Three Months EndedMarch 31, | Nine Months EndedMarch 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net income | $300,492 | $232,500 | $728,715 | $667,892 |
| Other comprehensive income, net of taxes: | ||||
| Unrealized gains (losses) on designated hedging instruments | 77,503 | (12,496) | 40,519 | (32,699) |
| Foreign currency translation gain (loss) adjustments | (134,457) | 20,787 | (33,297) | 83,569 |
| Comprehensive income | $243,538 | $240,791 | $735,937 | $718,762 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.